Assiut University has announced plans for a clinical trial to evaluate the potential of Electrical Cardiometry as a non-invasive method for hemodynamic monitoring in COPD patients admitted to the Respiratory Intensive Care Unit. Scheduled as a prospective evaluation, this study could contribute valuable insights to critical care medicine.
This innovative approach employs Electrical Cardiometry, a non-invasive technique that uses thoracic impedance measurements to assess cardiac function and hemodynamics in real-time. Researchers aim to determine the utility and accuracy of this technology in monitoring patients with chronic obstructive pulmonary disease (COPD) requiring intensive care.
Published: October 7, 2025
In this article
- What changed?
- Study details
- Expected impact
- Frequently Asked Questions
- Conclusion
- Disclaimer
- Announcement details
What changed?
The announcement highlights the initiation of a clinical trial at Assiut University, focusing on Electrical Cardiometry as a diagnostic and monitoring tool for COPD patients in critical conditions. While recruitment for the study has not yet begun, the project introduces medical device teams with potential advancements in non-invasive monitoring technologies.
Study details
What is Electrical Cardiometry?
Electrical Cardiometry is a non-invasive method to measure thoracic bioimpedance and provide real-time data regarding cardiac function and hemodynamics. This technology has been suggested as an alternative to invasive methods, potentially reducing procedural risks for patients.
Who will be involved in the trial?
The trial will focus on patients diagnosed with COPD and admitted to the Respiratory Intensive Care Unit. As outlined in the registration details, investigators aim to evaluate the reliability and accuracy of Electrical Cardiometry in this population for hemodynamic monitoring.
Expected impact
Why does it matter?
Non-invasive diagnostic tools like Electrical Cardiometry are increasingly important for enhancing patient safety and comfort while providing accurate clinical insights. For COPD patients, effective hemodynamic monitoring can be critical in avoiding complications. Findings from this study may influence clinical practices and adoption of non-invasive technologies.
Industry implications
For medical device developers, this trial highlights a growing demand for non-invasive solutions tailored to critical care use. Should Electrical Cardiometry prove successful, manufacturers may find opportunities to expand applications across diverse patient groups and settings.
Frequently Asked Questions
1. What is COPD and why is monitoring important?
Chronic obstructive pulmonary disease (COPD) affects the lungs and respiratory system, often leading to severe complications during hospital admissions. Monitoring is crucial for managing symptoms and avoiding escalations.
2. How does Electrical Cardiometry work?
It measures thoracic bioimpedance—changes in electrical resistance—to analyze cardiac output and other hemodynamic parameters without invasive equipment.
3. When will recruitment begin?
The study is listed as “not yet recruiting” at the time of this publication. Updated timelines may be available later on the ClinicalTrials.gov record.
4. Where can I find more information?
Further details can be accessed directly via the trial announcement link provided below.
Conclusion
The planned prospective evaluation of Electrical Cardiometry offers a promising step towards refining non-invasive techniques for critical care patients. Medical device teams and healthcare professionals should monitor results as they emerge, potentially influencing the adoption and regulatory pathways for similar tools.
Disclaimer
This post is for informational purposes aimed at healthcare professionals and medical device teams. It does not constitute legal or clinical advice. Readers should verify regulatory suitability independently.
Announcement details
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07208578?term=medical+device